Drugs / BCG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05468606 | Feb 2023 → Dec 2024 | Plasmodium falciparum malaria | Leiden University Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05468606 ↗ |
| Modality | Vaccine | “0.1 mL BCG vaccine intradermally” NCT05468606 ↗ |
| Route | Other | “0.1 mL BCG vaccine intradermally” NCT05468606 ↗ |